GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Assets | ₹4,190 Cr | ₹3,967 Cr | ₹3,410 Cr | ₹3,193 Cr | ₹4,520 Cr |
What is the latest Total Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Assets |
|---|---|
| Mar2026 | ₹4,190 Cr |
| Mar2025 | ₹3,967 Cr |
| Mar2024 | ₹3,410 Cr |
| Mar2023 | ₹3,193 Cr |
| Mar2022 | ₹4,520 Cr |
How is Total Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,190 Cr | 5.62 | |
| Mar2025 | ₹3,967 Cr | 16.33 | |
| Mar2024 | ₹3,410 Cr | 6.80 | |
| Mar2023 | ₹3,193 Cr | -29.36 | |
| Mar2022 | ₹4,520 Cr | - | |
Compare Total Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹49,119.2 Cr | 11.6% | 17.6% | 9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 11.6% |
17.6% |
9.4% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses